Nutritional genomics identifies a potential weight-loss resistance gene

December 07, 2005

Two obese people follow the same low-calorie diet and do not exercise, but one loses much more weight than the other. Genetic factors may explain this phenomenon, according to José Ordovas, PhD, director of the Nutrition and Genomics Laboratory at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University. In a study published in the Journal of Clinical Endocrinology & Metabolism, Ordovas and colleagues identified a variation in the perilipin gene that appears to render some people resistant to weight loss from calorie restriction. This research builds on their earlier work on perilipin and obesity.

"It is as if the connection between calorie intake and body weight is interrupted," explains Ordovas, who is also a professor at the Friedman School of Nutrition Science and Policy at Tufts. "Carriers of this gene variant appear to have more stable mechanisms for controlling their body weight," Ordovas says. "In people that have become obese, this leads to a blunting of the weight-loss effect we would expect to see with calorie restriction."

Andrew Greenberg, MD, director of the Obesity and Metabolism Laboratory at the USDA Center at Tufts, one of the scientists who discovered perilipin, notes that in an earlier study this same gene variant was linked with a lower risk of obesity, but in this study, it was associated with weight loss resistance.

"It may make sense," Greenberg says, "if we consider that this perilipin gene variant induces a sort of buffer against changes in how the body burns and stores food energy. It appears to protect against weight gain in lean women, while preventing weight loss in men and women who have become obese."

The clinical study was led by Dolores Corella, PhD, of the Genetic and Molecular Epidemiology Unit, University of Valencia, in Spain, who is a visiting scientist at the HNRCA and a long-term collaborator with Ordovas. These investigators studied 48 severely obese men and women who were following a low-calorie diet for one year. Subjects, who did have the more common variants of the perilipin gene lost an average of approximately 20 pounds during the study period. In contrast, carriers of the variant gene did not experience significant weight changes.

The researchers determined that the difference in weight loss between the two groups could not be explained by the fact that the variant gene carriers weighed less at the start of the study. When asked why the subjects had not lost more weight, Ordovas noted, "These subjects were closely followed during the study period and the compliance was considered to be excellent regardless of the perilipin genotype. Given the difficulty of keeping weight off long-term, the loss of 20 pounds is a significant achievement."

The perilipin gene controls the production of perilipin, a protein that regulates the release of fat from cells. The Tufts researchers' earlier study linking two variations in the perilipin gene to a lower risk of obesity in women was described in a Friedman Nutrition Note released earlier this year, entitled, "Genetics Research Unlocks a Key Regulator of Weight in Women."

Ordovas cautions, "First of all, it is very important to point out that both of these studies were conducted on the same general ethnic population in Spain. We do not know what we might find in other countries or ethnic groups. And secondly," he adds, "nutritional genomics is not yet in a position to contribute significantly to treatment of obese patients. But we are finally beginning to piece together how genetics might be used in the future, perhaps to help predict who is likely to respond well to dietary weight-loss interventions."
-end-
Corella D, Qi L, Sorli JV, Godoy D, Portolés O, Coltell O, Greenberg AS, Ordovas JM. The Journal of Clinical Endocrinology & Metabolism. 2005; 90(9): 5121-5126. "Obese Subjects Carrying the 11482G>A Polymorphism at the Perilipin Locus Are Resistant to Weight Loss after Dietary Energy Restriction."

Tufts University

Related Obesity Articles from Brightsurf:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.

Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.

New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal) http://www.cmaj.ca/lookup/doi/10.1503/cmaj.191707.

Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.

Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).

How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.

Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?

Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.

Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.

Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.

Read More: Obesity News and Obesity Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.